These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 14869347)

  • 1. The effect of dicoumarol on co-thromboplastin, a factor in blood concerned with the conversion of prothrombin to thrombin.
    MANN FD; BARKER NW; HURN M
    Blood; 1951 Sep; 6(9):838-44. PubMed ID: 14869347
    [No Abstract]   [Full Text] [Related]  

  • 2. BLOOD COAGULATION--A BASIC SCIENCE REVIEW.
    MILSTONE JH
    Conn Med; 1964 Sep; 28():653-6. PubMed ID: 14201316
    [No Abstract]   [Full Text] [Related]  

  • 3. The blood coagulation mechanism of frogs, with respect to the species specificity of thromboplastin, to intracardial thrombin injection, and to the effect of seasonal changes.
    SPITZER JJ; SPITZER JA
    Can J Med Sci; 1952 Oct; 30(5):420-4. PubMed ID: 12988136
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluctuations in the level of prothrombin, thrombin, free heparin and the activity of thromboplastin in the blood of patients after surgery on the organs of the intestinal cavity].
    PANAKHIAN AG
    Khirurgiia (Mosk); 1960 May; 36():113-9. PubMed ID: 14430077
    [No Abstract]   [Full Text] [Related]  

  • 5. [The relation of an erythrocytic factor to thromboplastin formation].
    DE VRIES SI; KETTENBORG HK; VAN DER POL ET
    Ned Tijdschr Geneeskd; 1955 Oct; 99(40):2967-74. PubMed ID: 13279960
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE ROLE OF THROMBIN GENERATION AND INACTIVATION IN HEMOSTATIC PHENOMENA].
    GARTNER H; LISIEWICZ J
    Acta Physiol Pol; 1964; 15():245-56. PubMed ID: 14227144
    [No Abstract]   [Full Text] [Related]  

  • 7. ROLE OF THROMBIN IN PROTHROMBIN ACTIVATION.
    SEEGERS WH; SCHROEER H; HEENE D
    Thromb Diath Haemorrh; 1964 Dec; 12():484-8. PubMed ID: 14254705
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 9. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 10. Dicumarol therapy controlled by the stabilized thrombin method for determination of prothrombin.
    STERNBERGER LA
    Blood; 1949 Oct; 4(10):1131-41 !V17(49) R-00935. PubMed ID: 18139386
    [No Abstract]   [Full Text] [Related]  

  • 11. [The serum factor of prothrombin conversion acceleration. The specificity of thromboplastin].
    BURSTEIN M
    J Physiol (Paris); 1950; 42(4):865-75. PubMed ID: 14825172
    [No Abstract]   [Full Text] [Related]  

  • 12. Blood thrombotest versus prothrombin test. Comparison in patients maintained on bishydroxycoumarin and related drugs.
    CURRENS JH; GRANT M
    JAMA; 1961 Nov; 178():760-2. PubMed ID: 13882715
    [No Abstract]   [Full Text] [Related]  

  • 13. Complexes of protein-free lipid thromboplastin and prothrombin conversion factors; identifiable intermediates in the coagulation of blood.
    MANN FD; HURN MM
    Am J Physiol; 1955 Aug; 182(2):319-24. PubMed ID: 13258809
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on the efficiency of vitamin K1 in small doses as antidote against anticoagulants of the dicoumarol type.
    GEILL T; LUND E; DAM H; SØNDERGAARD E
    Scand J Clin Lab Invest; 1954; 6(3):203-9. PubMed ID: 13205146
    [No Abstract]   [Full Text] [Related]  

  • 15. The coagulation defect in hemophilia with particular reference to the conversion of prothrombin to thrombin and the evolution of the prothrombin conversion accelerator.
    ALEXANDER B; DE VRIES A
    Blood; 1949 Jun; 4(6):752-8. PubMed ID: 18129761
    [No Abstract]   [Full Text] [Related]  

  • 16. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of dicoumarol and salicylates given together on the prothrombin concentration of human blood.
    GREEN P
    Manit Med Rev; 1950 Jan; 30(1):13. PubMed ID: 15398968
    [No Abstract]   [Full Text] [Related]  

  • 18. A factor in serum which accelerates the conversion of prothrombin to thrombin; its evolution with special reference to the influence of conditions which affect blood coagulation.
    ALEXANDER B; DE VRIES A; GOLDSTEIN R
    Blood; 1949 Jun; 4(6):739-46. PubMed ID: 18129759
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of water-soluble preparations of vitamin K in dicumarol-induced hypoprothrombinemia.
    SHAPIRO S; WEINER M; SIMSON G
    N Engl J Med; 1950 Nov; 243(20):775-9. PubMed ID: 14780370
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.